238 related articles for article (PubMed ID: 23028668)
1. Triterpenoid dihydro-CDDO-trifluoroethyl amide protects against maladaptive cardiac remodeling and dysfunction in mice: a critical role of Nrf2.
Xing Y; Niu T; Wang W; Li J; Li S; Janicki JS; Ruiz S; Meyer CJ; Wang XL; Tang D; Zhao Y; Cui T
PLoS One; 2012; 7(9):e44899. PubMed ID: 23028668
[TBL] [Abstract][Full Text] [Related]
2. Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes.
Ichikawa T; Li J; Meyer CJ; Janicki JS; Hannink M; Cui T
PLoS One; 2009 Dec; 4(12):e8391. PubMed ID: 20027226
[TBL] [Abstract][Full Text] [Related]
3. The NRF2 activator DH404 attenuates adverse ventricular remodeling post-myocardial infarction by modifying redox signalling.
Bubb KJ; Kok C; Tang O; Rasko NB; Birgisdottir AB; Hansen T; Ritchie R; Bhindi R; Reisman SA; Meyer C; Ward K; Karimi Galougahi K; Figtree GA
Free Radic Biol Med; 2017 Jul; 108():585-594. PubMed ID: 28438659
[TBL] [Abstract][Full Text] [Related]
4. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney disease.
Aminzadeh MA; Reisman SA; Vaziri ND; Shelkovnikov S; Farzaneh SH; Khazaeli M; Meyer CJ
Redox Biol; 2013; 1(1):527-31. PubMed ID: 24363993
[TBL] [Abstract][Full Text] [Related]
5. The effect of Nrf2 pathway activation on human pancreatic islet cells.
Masuda Y; Vaziri ND; Li S; Le A; Hajighasemi-Ossareh M; Robles L; Foster CE; Stamos MJ; Al-Abodullah I; Ricordi C; Ichii H
PLoS One; 2015; 10(6):e0131012. PubMed ID: 26110640
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 protects against maladaptive cardiac responses to hemodynamic stress.
Li J; Ichikawa T; Villacorta L; Janicki JS; Brower GL; Yamamoto M; Cui T
Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1843-50. PubMed ID: 19592468
[TBL] [Abstract][Full Text] [Related]
7. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease.
Aminzadeh MA; Reisman SA; Vaziri ND; Khazaeli M; Yuan J; Meyer CJ
Xenobiotica; 2014 Jun; 44(6):570-8. PubMed ID: 24195589
[TBL] [Abstract][Full Text] [Related]
8. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T
J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309
[TBL] [Abstract][Full Text] [Related]
9. The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction.
Sharma A; Rizky L; Stefanovic N; Tate M; Ritchie RH; Ward KW; de Haan JB
Cardiovasc Diabetol; 2017 Mar; 16(1):33. PubMed ID: 28253885
[TBL] [Abstract][Full Text] [Related]
10. Dihydro-CDDO-trifluoroethyl amide suppresses inflammatory responses in macrophages via activation of Nrf2.
Li B; Abdalrahman A; Lai Y; Janicki JS; Ward KW; Meyer CJ; Wang XL; Tang D; Cui T
Biochem Biophys Res Commun; 2014 Feb; 444(4):555-61. PubMed ID: 24486487
[TBL] [Abstract][Full Text] [Related]
11. Synthetic Triterpenoid RTA dh404 (CDDO-dhTFEA) Ameliorates Acute Pancreatitis.
Robles L; Vaziri ND; Li S; Masuda Y; Takasu C; Takasu M; Vo K; Farzaneh SH; Stamos MJ; Ichii H
Pancreas; 2016; 45(5):720-9. PubMed ID: 26495793
[TBL] [Abstract][Full Text] [Related]
12. Raf kinase inhibitor protein mediates myocardial fibrosis under conditions of enhanced myocardial oxidative stress.
Kazakov A; Hall RA; Werner C; Meier T; Trouvain A; Rodionycheva S; Nickel A; Lammert F; Maack C; Böhm M; Laufs U
Basic Res Cardiol; 2018 Sep; 113(6):42. PubMed ID: 30191336
[TBL] [Abstract][Full Text] [Related]
13. Nrf2-Mediated Cardiac Maladaptive Remodeling and Dysfunction in a Setting of Autophagy Insufficiency.
Qin Q; Qu C; Niu T; Zang H; Qi L; Lyu L; Wang X; Nagarkatti M; Nagarkatti P; Janicki JS; Wang XL; Cui T
Hypertension; 2016 Jan; 67(1):107-17. PubMed ID: 26573705
[TBL] [Abstract][Full Text] [Related]
14. Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins.
Wang W; Li S; Wang H; Li B; Shao L; Lai Y; Horvath G; Wang Q; Yamamoto M; Janicki JS; Wang XL; Tang D; Cui T
J Mol Cell Cardiol; 2014 Jul; 72():305-15. PubMed ID: 24747945
[TBL] [Abstract][Full Text] [Related]
15. Peroxiredoxin-1 ameliorates pressure overload-induced cardiac hypertrophy and fibrosis.
Tang C; Yin G; Huang C; Wang H; Gao J; Luo J; Zhang Z; Wang J; Hong J; Chai X
Biomed Pharmacother; 2020 Sep; 129():110357. PubMed ID: 32531679
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of Nrf2/HO-1 and inhibition of TGF-β1/Smad2/3 signaling axis by daphnetin alleviates transverse aortic constriction-induced cardiac remodeling in mice.
Syed AM; Kundu S; Ram C; Kulhari U; Kumar A; Mugale MN; Mohapatra P; Murty US; Sahu BD
Free Radic Biol Med; 2022 Jun; 186():17-30. PubMed ID: 35513128
[TBL] [Abstract][Full Text] [Related]
17. Zingerone attenuates aortic banding-induced cardiac remodelling via activating the eNOS/Nrf2 pathway.
Liu C; Wu QQ; Cai ZL; Xie SY; Duan MX; Xie QW; Yuan Y; Deng W; Tang QZ
J Cell Mol Med; 2019 Sep; 23(9):6466-6478. PubMed ID: 31293067
[TBL] [Abstract][Full Text] [Related]
18. An essential role of Nrf2 in American ginseng-mediated anti-oxidative actions in cardiomyocytes.
Li J; Ichikawa T; Jin Y; Hofseth LJ; Nagarkatti P; Nagarkatti M; Windust A; Cui T
J Ethnopharmacol; 2010 Jul; 130(2):222-30. PubMed ID: 20447451
[TBL] [Abstract][Full Text] [Related]
19. Azilsartan ameliorates ventricular hypertrophy in rats suffering from pressure overload-induced cardiac hypertrophy by activating the Keap1-Nrf2 signalling pathway.
Hou N; Li LR; Shi YY; Yuan WC; Zhao GJ; Liu XW; Cai SA; Huang Y; Zhan HX; Pan WB; Luo CF
J Pharm Pharmacol; 2021 Dec; 73(12):1715-1725. PubMed ID: 34343333
[TBL] [Abstract][Full Text] [Related]
20. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
